CCL2 and prostate cancer: Although MCP-1/CCL2 was produced by both monocytes and prostate cancer cells, it appears that the CCL2 production was not simply driven by a positive feedback loop, since the CCR2 inhibitor RS102895 did not affect the CCL2 levels in the co-cultures.